- Investing Ideas
- South Korean Pharmaceuticals & Biotech Sustainable Track Record
South Korean Pharmaceuticals & Biotech Sustainable Track Record
Results
6
Companies which have reinvested earnings to sustain 10% yearly growth over 5 years.
6 companies
PharmaResearch
Market Cap: ₩3.7t
Operates as a biopharmaceutical company primarily in South Korea.
A214450
₩357,000.00
7D
6.1%
1Y
-36.0%
Samsung BiologicsLtd
Market Cap: ₩70.3t
Together with its subsidiaries engages in the manufacturing, commercializing, distributing, and selling of biopharmaceuticals products in South Korea, Europe, the United States, and internationally.
A207940
₩1,518,000.00
7D
8.7%
1Y
-7.4%
Oscotec
Market Cap: ₩1.2t
Operates as a biotechnology company, engages in the drug development, functional materials and related products, and dental bone graft material businesses.
A039200
₩31,050.00
7D
3.0%
1Y
-8.9%
JW Shinyak
Market Cap: ₩106.9b
Engages in the research, development, production, and sale of medicines and medical supplies in South Korea.
A067290
₩1,914.00
7D
-2.8%
1Y
21.8%
JW Holdings
Market Cap: ₩267.1b
Operates as a healthcare company in South Korea, the United States, Japan, China, and internationally.
A096760
₩3,860.00
7D
-1.2%
1Y
4.2%
SK Biopharmaceuticals
Market Cap: ₩6.3t
A pharmaceutical company, engages in the research, development, and commercialization of drugs for the treatment of central nervous system disorders.
A326030
₩80,600.00
7D
1.5%
1Y
-21.4%